Abstract:Retinopathy of prematurity (ROP) is a leading cause of childhood blindness in preterm infants. The incidence of ROP varies widely across countries, with rates as high as 30% in some regions. This study investigated the incidence, risk factors, treatment, and mortality of ROP patients in Germany. Data were extracted from the German Federal Statistical Office (Destatis) diagnosis-related group (DRG) and Institute for the Remuneration System in Hospitals (InEK) databases. Patients with a secondary diagnosis of ROP (ICD-10 code H35.1) in the first 28 days of life were included. Data were extracted for patients admitted between January 1, 2019 and December 31, 2019. The diagnoses and procedures were determined using the German version of the International Classification of Diseases (ICD-10-GM) and the German procedure coding system (OPS). The codes 5-154.xx, 5-155.xx, 8-020.xx, 5-156.9, 6-003.(c&d), 6-007.(2&8) were utilised to denote different ocular treatments. Patient Clinical Complexity Levels were extracted and used to compare ROP with non-ROP patients. A total of 1326 patients with ROP were identified. The incidence of ROP is estimated to be 17.04 per 10,000 live births. The incidence was highest in infants with birth weights less than 500 g and decreased with increasing birth weight. The most common risk factors for ROP were low birth weight, male sex, and prematurity. Of the infants with ROP, 7.2% required ocular treatment. The most common treatment was intraocular injections, followed by photocoagulation. No surgical treatment was required for any of the infants during the study period. The mortality rate for infants with ROP was 60.33 per 10,000. This is higher than the overall neonatal death rate of 24.2 per 10,000. Conclusions: This study found that the incidence of ROP in Germany is similar to that in other developed countries. The study also found that the mortality rate for infants with ROP is higher than the overall neonatal death rate. These findings highlight the importance of early detection and treatment of ROP in preterm infants. What is known: • ROP is a severe eye condition often affecting preterm infants. • Previous data are limited in scope and generalizability. What is new: • Based on a national database, our study found ROP incidence to be 17.04 per 10,000 new births, higher in males (17.71) than in females (16.34). • 7.2% of ROP cases required ocular treatment, inversely correlated with birth weight. • High rates of multimorbidity such as neonatal jaundice (84.69%), respiratory distress syndrome (80.84%), and apnea (78.88%) were observed.

Visual impairment due to retinopathy of prematurity and concomitant disabilities in the Netherlands

Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017

Visual impairment burden in retinopathy of prematurity: trends, inequalities, and improvement gaps

The incidence of retinopathy of prematurity in neonates in Germany in 2019; a nationwide epidemiological cohort study

Incidence, Risk Factors, and Treatment Outcomes in a Tertiary Care Center

Trends in Retinopathy of Prematurity Among Preterm Infants in California, 2012 to 2021

Incidence, Risk Factors and Development of Retinopathy of Prematurity in Mid-Preterm and Late-Preterm Infants

Vision on wheels: Technician-assisted retinopathy of prematurity screening in rural Tamil Nadu and Andhra Pradesh: 2018–2021 Project Report

Global Prevalence and Severity of Retinopathy of Prematurity over the Last Four Decades (1985–2021): A Systematic Review and Meta-Analysis

Retinopathy of prematurity in South Africa: an assessment of needs, resources and requirements for screening programmes

Increased risk of retinopathy of prematurity since increased O2 saturation targets: A multi-centre study

Incidence of Retinopathy of Prematurity Treatment in Extremely Preterm Infants in China.

Impact of retinopathy of prematurity on ocular structures and visual functions

Cerebral injury and retinopathy as risk factors for blindness in extremely preterm infants

Retinopathy of Prematurity: A Global Perspective and Recent Developments.

Incidence and Risk Factor Analysis of Retinopathy of Prematurity

Prevalence and pattern of retinopathy of prematurity at two national referral hospitals in Uganda: a cross-sectional study

The U.S. National Trend for Retinopathy of Prematurity

Two-Year Outcomes of Infants with Stage 2 or Higher Retinopathy of Prematurity: Results from a Large Multicenter Registry

Validation of a Published Model to Reduce Burden of Retinopathy of Prematurity Screening

Retinopathy of Prematurity in Eight Portuguese Neonatal Intensive Care Units: Incidence, Risk Factors, and Progression-A Prospective Multicenter Study